Skip to content

Clinical study on the truncation and torsion effect of the Xinjia Bushen Naqi decoction combined with Liuzijue Exercise in the treatment of GOLD II - III COPD patients with decreased pulmonary ventilation

Clinical study on the truncation and torsion effect of the Xinjia Bushen Naqi decoction combined with Liuzijue Exercise in the treatment of GOLD II - III COPD patients with decreased pulmonary ventilation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037011
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria of western medicine for COPD and are in the stable stage of moderate or severe COPD, and patients in group B and C who meet the criteria for comprehensive assessment of COPD; (2) Meet the classification standard of TCM lung and kidney qi deficiency syndrome; (3) 50 <= age <= 75, regardless of gender; (4) Those with clear consciousness and independent judgment; (5) Sign informed consent and agree to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Patients with asthma, bronchiectasis, pulmonary cystic fibrosis, pulmonary tuberculosis, lung cancer or other known causes and restricted airflow with characteristic pathological manifestations; (2) Exertional shortness of breath caused by coronary heart disease, heart valve disease, etc.;Combined with uremia, hyperthyroidism, heart failure; (3) Patients with abnormal liver function (ASK, ALT more than 1.2 times of normal on-line level), or HbsAg, HbeAg and HbcAg were both positive; (4) Uncontrolled hypertension (at rest, SBP >= 180mmHg or DBP >= 100mmHg); (5) Patients with narrow-angle glaucoma; (6) 18 kg/m2 = 25kg/m2; (7) Complicated with severe peptic ulcer, malignant tumor, AIDS and autoimmune disease; (8) women during pregnancy or lactation;Those with mental, intellectual and thinking abnormalities that make them unable to cooperate; (9) persons with legal disabilities; (10) those who have participated in or are participating in other clinical trials in the past three months; (11) Patients who are allergic to the drugs and components used in this study and do not want to accept clinical observers.

Design outcomes

Primary

MeasureTime frame
exercise endurance time;

Secondary

MeasureTime frame
lung function;COPD assessment test;modified British medical research council;

Countries

China

Contacts

Public ContactLu Zhenhui

Longhua Hospital Shanghai University of Traditional Chinese Medicine

Dr_luzh@shutcm.edu.cn+86 13817729859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026